Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
International Journal of Biological Macromolecules|October 18, 2025
Characterization of ITIH6, a novel inter-α-inhibitor family member with prognostic significance in cholangiocarcinomaJia-Xin Shi, Michael Rose, Lara Heij, et al.
International Journal of Molecular Sciences|September 10, 2021
Epigenetic Clocks Are Not Accelerated in COVID-19 PatientsJulia Franzen, Selina Nüchtern, Vithurithra Tharmapalan, et al.
World Journal of Surgical Oncology|February 7, 2024
Preoperative predictors for non-resectability in perihilar cholangiocarcinomaCarlos Constantin Otto, Anna Mantas, Lara Rosaline Heij, et al.
The Journal of Pathology|November 9, 2004
Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survivalGlen Kristiansen, Christian Pilarsky, Christoph Wissmann, et al.
Gynecologic and Obstetric Investigation|July 25, 2017
Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and PAI-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian Cancer: A Study of the Tumor Bank Ovarian Cancer NetworkDominique Koensgen, Matthias B Stope, Ivana Tuerbachova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Prognostic relevance of AGR2 expression in breast cancerFlorian Rudolf Fritzsche, Edgar Dahl, Stefan Pahl, et al.
Liver Cancer|May 31, 2022
Genetic Variant of CXCR1 (rs2234671) Associates with Clinical Outcome in Perihilar CholangiocarcinomaIsabella Lurje, Zoltan Czigany, Jan Bednarsch, et al.
BMC Cancer|December 15, 2012
Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosisNuran Bektas Serce, Andreas Boesl, Irina Klaman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2006
Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancerEdgar Dahl, Glen Kristiansen, Kathrin Gottlob, et al.
International Journal of Cancer|June 19, 2008
Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensityOleg Gluz, Peter Wild, Robert Meiler, et al.
Pageof 14